Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You go to NWBO MB and thumsy up Exwannabe's trash post?
LOL, I thought you are a believer of the this NoCure TinCanHat power???
I guess NOT.. LOL
LOL - THI HAT HAS NO CHNCE. THE NON-CURE IS OUT IN THE OPPEN//
SP HAS DROPPED BY OVER 100% THIS YEAR.... AND GOING LOWER IMO....
$NVCR has a great chance of retaking the 50dma, perhaps as so as tomorrow! GLTA
Won't make a diff. SP will continue to go down IMO, as NoCure is a fake take on cancer biology, which tinHAT has nothing to do with.....
Results of LUNAR at ASCO. Also, nine other posters from Novocure-sponsored and partner programs to be presented as well. In addition, the company will host an investor event https://www.businesswire.com/news/home/20230426005597/en/Novocure-Announces-Presentation-of-Results-of-the-LUNAR-Phase-3-Clinical-Trial-in-Non-Small-Cell-Lung-Cancer-at-2023-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting
LOL - Sounds like Jonk to me
LOL - NoCure has no future - Just pile of J U N K..... Appealing to the Unknowledgeable & P A I D P umpies..
Crash, $NVCR has a MUCH brighter future than the scam stock you've been posting on non-stop! At one time I also believed $NWBO was a legitimate company. I invested a lot of money twice and all proceeds went to several charities including my original buy-ins! I realized Linda Powers didn't have the nut and had been bluffing all along. The DCVAX PII trial that was converted to a PIII trial failed, It's bloody obvious! I wish this wasn't the case.
I have become very good friends with a couple of great people on the $NWBO board and was really hoping and praying for them and the patients for this to be a cure but it's not. Friends I will see financially that they are made whole, patients unfortunately I don't possess the ability to do that.
By the time you can post again, I expect $NWBO to be trading at 3-year lows, that's really sad. Just so you know, for any biotech company I invest in, all proceeds including original investment go to worthwhile charities. GLTA
As someone once said, ''Never argue with an idiot. They will only bring you down to their level and beat you with experience."
Novocure has no product that works. That's why their management constantly dump their stock.
Rarely do I capitalize on buying at the bottom, but it would appear I did just that with $NVCR! Mate, what's that saying, buy when others are fearful, be fearful when others are buying? GLTA
Opinion (bad one)
And for someone who is always talking about saving patients currently that is one of the best options for GBM that is APPROVED
Can you believe this 18 months ago was trading around $230+? Now is $57 and going down.
You missing the fact that the tinfoil is fake... will be gone soon.
Must have also missed all analysts downgrading it....
And that SP has dropped by about 50% during last month...
Quoting AACR the only one to publish Adam Feuersteins hit piece from May 10th. and afterwards withdraw it. AACR who continously are granting NVCR awards.
Personally I love the history of the NVCR board on Ihub especially in comparison to NWBO. A stroll down menory lane from last year.
I also love the recent development. That NVCR announced a PR about their LUNAR "device" before a weekend, springing the SP to $118. SEC filing shows that almost all of management used that timeframe to sell a lot of shares before another SEC filing after the weekend showed NVCR only had around 3.400 patients GLOBALLY and can not attract more.
SP dropped BAAAM.
But no worries. Afterwards a lot in the management secured shares at $0 and a lot sold again late February and early March.
BAAAAM.
$1M just directly into the pocket.
And now JP Morgan has downgraded NVCR to $50. The SP has already dropped from $118 to $57 and waddayaknow, completely without spoofing and counterfitting involved. STILL their SP fell more than NWBO.
Speaks volumes where NVCR are going. Their "science" is being eradicated by personal vaccines actually helping patients to get better, not stay status quo for a while a the price of $21.000 a month.
All the while NO ONE from the NWBO management have sold one share. Not above $2 either. For years.
But obviously Jerry Jasinowski felt like adding for $600.000 at $0.85 in December.
Also,
Tumor treating fields induce immune modulation in non-small cell lung cancer https://www.abstractsonline.com/pp8/#!/10828/presentation/3202
Investigation of sponge property for enhanced concurrent tumor treating fields and radiotherapy for glioblastoma https://www.abstractsonline.com/pp8/#!/10828/presentation/5415
TTFields-prolonged the PFS of epithelioid glioblastoma patient: a case report https://www.abstractsonline.com/pp8/#!/10828/presentation/1567
TTFields combined with temozolomide and immunotherapy show long-term PFS on a GBM patients with multiple negative prognostic factors https://www.abstractsonline.com/pp8/#!/10828/presentation/3145
Safety and efficacy of Tumor Treating Fields (TTFields) combined with bevacizumab and systemic chemotherapy in recurrent GBM https://www.abstractsonline.com/pp8/#!/10828/presentation/10455
The impact of tumor-treating fields on cancer stem-like cells isolated from the sub-ventricular zone of glioblastoma patients https://www.abstractsonline.com/pp8/#!/10828/presentation/2753
AACR abstracts (the event is next month).
TRIDENT phase 3 study (EF-32): First-line Tumor Treating Fields (TTFields; 200 kHz) therapy concomitant with chemo-radiation, followed by maintenance TTFields/temozolomide in newly diagnosed glioblastoma https://www.abstractsonline.com/pp8/#!/10828/presentation/10498
Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer https://www.abstractsonline.com/pp8/#!/10828/presentation/2709
Tumor treating fields combined with the PULSAR paradigm for radiotherapy and an immune checkpoint inhibitor enhances antitumor efficacy in vivo https://www.abstractsonline.com/pp8/#!/10828/presentation/4735
Establishing the cytotoxic benefit of Tumor Treating Fields on radiation sensitive and acquired radiation resistant glioblastoma patient derived xenograft pairs https://www.abstractsonline.com/pp8/#!/10828/presentation/1473
Theoretical basis and formula for tumor-treating fields dose-response curves https://www.abstractsonline.com/pp8/#!/10828/presentation/1498
In vitro and in vivo investigation of tumor treating fields for treatment of spinal metastasis https://www.abstractsonline.com/pp8/#!/10828/presentation/2371
Sensitizing cancer cell to doxorubicin by tumor treating fields (TTFields)-induced, elevated membrane permeability https://www.abstractsonline.com/pp8/#!/10828/presentation/9326
Tumor treating fields exposure causes an imbalance of reactive oxygen homeostasis likely through the cytosolic function of the fanconi's anemia genes https://www.abstractsonline.com/pp8/#!/10828/presentation/5953
Treatment of gastric cancer cells with tumor treating fields (TTFields) and concomitant FOLFOX https://www.abstractsonline.com/pp8/#!/10828/presentation/2737
Evaluation of tumor treating fields (TTFields) effects at 200 kHz on a glioblastoma, an anaplastic ependymoma and an oligodendroglioma sample in a patient-derived ex vivo organoid model https://www.abstractsonline.com/pp8/#!/10828/presentation/2328
PI3K inhibition sensitize cancer cells to tumor treating fields (TTFields) https://www.abstractsonline.com/pp8/#!/10828/presentation/1615
Pan cancer transcriptomic response to tumor treating fields (TTFields) https://www.abstractsonline.com/pp8/#!/10828/presentation/1770
Association of Tumor Treating Fields (TTFields) with survival in newly diagnosed glioblastoma: A systematic review and meta-analysis https://www.abstractsonline.com/pp8/#!/10828/presentation/1556
Inhibition of AURKA destabilizes glioblastoma primary cilia and sensitizes cells to tumor treating fields (TTFields) in vitro and ex vivo https://www.abstractsonline.com/pp8/#!/10828/presentation/7221
Enhancing treatment efficacy of glioblastoma cell lines by adding tumor treating fields (TTFields) to temozolomide and lomustine https://www.abstractsonline.com/pp8/#!/10828/presentation/1826
Tumor treating fields (TTFields) concomitant with PARP inhibitors or carboplatin for treatment of ovarian cancer cell lines https://www.abstractsonline.com/pp8/#!/10828/presentation/1832
CLIC1 and CLIC4 ion channels as bioelectric targets for tumor treating fields in pediatric high-grade glioma https://www.abstractsonline.com/pp8/#!/10828/presentation/5522
Patients with glioblastoma (GBM) treated with tumor treating fields (TTFields) therapy: post-marketing safety data over the last decade https://www.abstractsonline.com/pp8/#!/10828/presentation/1564
TTFields reduce sensitivity in glioblastoma is associated with the functional expression of the chloride intracellular channel 1 and with voltage dependent sodium channel https://www.abstractsonline.com/pp8/#!/10828/presentation/2043
Simply put, no.
Hello everyone, I got back into $NVCR this morning, 5K starter shares, will add on weakness! GLTA
Novocure aims to plough a new field https://www.evaluate.com/vantage/articles/interviews/novocure-aims-plough-new-field
Why HyGro is so worried??. He spends lots of time on NWBO MB. hummm
Ignore it.
Today News: After a review of Novocure’s future needs, Ely Benaim, M.D., Chief Medical Officer, will step down from his role and leave the company.
Very Telling Where this is headed....
Very Telling. The 6 officers combined sold over 260,000 shares all about $100/Share..
That's over $26M worth of shares they dumped!!
Did anyone else read this telling post
It's strange there's no activity on this board. Something doesn't seem right.
How's it going?
The Big Short - SCAM alert- The heat cap is at best as good as CHEMO!! IMO
Anyone else think this thing is a high level scam. I don’t think they have one 5 yr survivor
Did the CEO dump virtually his entire position? WTF is that about
You got that Absolutely right norisknorewards..
NVCR ends is closer than what that dude wishes not to be...
The device is no better than CHEMO!!
Easiest short he said
FDA Cleared CHEMO as well just incase... And that has miserably failed///
There is absolutely NO CURE in NoVoCure!!
Best Short EVER IMO
This below statement from their PR confirms that fact!!
".....which has the Potential to meaningfully extend patient survival beyond what was previously possible.,& that says it all. |the Potential .. to extend ..Survival" ... Its all that she wrote~~~~
Could be this am conference today?
Novocure plans to release the full results of the LUNAR study at a future medical conference. Novocure expects to file a Premarket Approval application with the U.S. Food and Drug Administration (FDA) in the second half of 2023. Novocure also expects to file for a CE Mark in the European Union concurrently with the FDA submission.
“We are pleased with the positive readout of the LUNAR study. Prior to LUNAR, the last phase 3 trial to lead to significant improvement in overall survival in late-stage, platinum-resistant non-small cell lung cancer was six years ago, underlining the difficulty in treating this disease,” said William Doyle, Novocure’s Executive Chairman. “We are also pleased by the profound performance of the TTFields together with immunotherapy, which has the potential to meaningfully extend patient survival beyond what was previously possible. I would like to thank our patients and investigators for their courage and dedication in completing LUNAR. And, I would like to thank Novocure’s employees for their unrelenting commitment to patients and their perseverance in propelling Novocure to this major milestone.”
“We are excited about the potential of TTFields to address the unmet medical needs of lung cancer patients around the world. In China, lung cancer is the most common cancer type with approximately 700,000 new NSCLC cases diagnosed each year,” said Dr. Samantha Du, Founder, Chairperson, and CEO of Zai Lab. “We are pleased to contribute and be a part of the LUNAR study and this partnership is yet another great example of how collaboration benefits everyone.”
Novocure plans to release the full results of the LUNAR study at a future medical conference. Novocure expects to file a Premarket Approval application with the U.S. Food and Drug Administration (FDA) in the second half of 2023. Novocure also expects to file for a CE Mark in the European Union concurrently with the FDA submission.
I penny pumper writing a narrative that's about to get burnt. Fda clearance is huge!!
NVCR microwave device hype will not last and rapidly fading!!
Those who understand how it works know that its application is at best comparable to chemo in terms of effectiveness & the real life experiences of the prescribing doctors & their cancer patients has been increasingly confirming that!!
Why do you think with a bloated $10B market cap, its earnings are non-existence and dropping??
Comparatively speaking, Chemo kills the cancer as well as the normal cells..
And the helmet, based on it claim mode of action of interfering with replication of fast dividing cells, such as cancer cells, inhibit the division of those cells at the site where the microwaves are targeting. Obviously elsewhere in the body, the cancer cells lives happily and keep invading..
Now consider the fact that activated immune system effector cells, such as the T-cells, are also fast dividing. Meaning that the microwaves also inhibit division of the activated immune cells thus, inhibiting the division of the activated immune cells that might have been estimated in some ways. A defeated claim for immune cell activation!!
So the microwaves Inhibit not only cancer cells replication, but also, activated immune cell replication IMO..
And IMO, the lack of interest of the medical community based on the real life experience of their patients as well as their poor quality of their remaining life at massive cost to them are all supportive of that view!!
A new & innovative alternative that stimulate the totality of the naturally occurring immune system from within is urgently needed!!
LOL -- I tried to short this a couple of time. Got my ass kicked.
$NVCR: You said it....... ust hit $185 in PreMarket
WOW.................. whatta MONSTER move.
GO $NVCR
Followers
|
28
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
553
|
Created
|
10/07/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |